Giuseppe
Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]
M A Degail<SUP>1</SUP><SUP>,2</SUP>, G J Hughes (
)<SUP>3</SUP>, C Maule<SUP>4</SUP>, C Holmes<SUP>4</SUP>, M Lilley<SUP>5</SUP>, R Pebody<SUP>1</SUP>, J Bonnet<SUP>4</SUP>, A Bermingham<SUP>1</SUP>, S Bracebridge<SUP>3</SUP>
Citation style for this article: Degail MA, Hughes GJ, Maule C, Holmes C, Lilley M, Pebody R, Bonnet J, Bermingham A, Bracebridge S. A human metapneumovirus outbreak at a community hospital in England, July to September 2010. Euro Surveill. 2012;17(15)
ii=20145. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20145
Date of submission: 20 September 2011 <HR>We describe an outbreak of human metapneumovirus (hMPV) which occurred in July?September 2010 at a community hospital in the East of England. Based on the medical and nursing records, cases were retrospectively defined as suspected if they had had an influenza-like illness (ILI), and probable if they had had an ILI and an epidemiological link to a laboratory-confirmed case. Of a total of 17 symptomatic inpatients, five were classified as probable cases, five were laboratory confirmed and seven were suspected. The attack rate was 29.4% for confirmed and probable cases combined. The median age of symptomatic inpatients was 85 years-old (range 68?96) and the majority (16/17) of symptomatic inpatients had an underlying medical condition. Control measures introduced appeared to restrict further exposure of susceptible patients to infection although modelling suggested that up to four of 10 confirmed and probable cases (40%) could have been prevented through more timely diagnosis and recognition of an outbreak. These findings suggest that there should be increased awareness of hMPV infection within healthcare settings, particularly when the population at risk has a high prevalence of underlying co-morbidities.
- ------
Eurosurveillance, Volume 17, Issue 15, 12 April 2012
Surveillance and outbreak reports
A human metapneumovirus outbreak at a community hospital in England, July to September 2010
Surveillance and outbreak reports
A human metapneumovirus outbreak at a community hospital in England, July to September 2010
M A Degail<SUP>1</SUP><SUP>,2</SUP>, G J Hughes (
- Health Protection Agency, Colindale, United Kingdom
- European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
- Health Protection Agency East of England, Cambridge, United Kingdom
- Hertfordshire Community NHS Trust, Welwyn Garden City, United Kingdom
- Bedfordshire and Hertfordshire Health Protection Unit, Letchworth, United Kingdom
Citation style for this article: Degail MA, Hughes GJ, Maule C, Holmes C, Lilley M, Pebody R, Bonnet J, Bermingham A, Bracebridge S. A human metapneumovirus outbreak at a community hospital in England, July to September 2010. Euro Surveill. 2012;17(15)
ii=20145. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20145 Date of submission: 20 September 2011 <HR>We describe an outbreak of human metapneumovirus (hMPV) which occurred in July?September 2010 at a community hospital in the East of England. Based on the medical and nursing records, cases were retrospectively defined as suspected if they had had an influenza-like illness (ILI), and probable if they had had an ILI and an epidemiological link to a laboratory-confirmed case. Of a total of 17 symptomatic inpatients, five were classified as probable cases, five were laboratory confirmed and seven were suspected. The attack rate was 29.4% for confirmed and probable cases combined. The median age of symptomatic inpatients was 85 years-old (range 68?96) and the majority (16/17) of symptomatic inpatients had an underlying medical condition. Control measures introduced appeared to restrict further exposure of susceptible patients to infection although modelling suggested that up to four of 10 confirmed and probable cases (40%) could have been prevented through more timely diagnosis and recognition of an outbreak. These findings suggest that there should be increased awareness of hMPV infection within healthcare settings, particularly when the population at risk has a high prevalence of underlying co-morbidities.